MINDSET Care Limited is the registered charity of the Jardine Matheson Group in Singapore, established to make a tangible difference to the local mental health community.
For Inclusivity. For Mental Health.
Foster open conversations to create awareness and acceptance of mental illness
Bridge community gaps as corporate stewards to increase mindshare and channel support for mental health
Jardines MINDSET aims to raise awareness of the understanding of mental health issues to change attitudes and the negative perception attached to it. We seek to provide a holistic approach towards supporting mental health persons-in-recovery, their families and caregivers, as well as mental health social service agencies, through our five focus areas.
To find out more, visit our website at www.mindset.com.sg.
Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases.
We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.
Our commitment - Tirelessly Dedicated to Restoring Brain Health, So Everyone Can Be Their Best
Bettering the lives of people living with brain diseases requires a multifaceted approach. Beyond developing transformative medical therapies, we strive to make a difference for patients, by working to increase support to affected families and engaging with communities to create broader social acceptance of people living with brain diseases.
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.
In pharmaceuticals, Otsuka is a leader in the challenging areas of mental, renal and cardiovascular health and has additional research programs in oncology and on several under-addressed diseases including tuberculosis, a significant global public health issue. These commitments illustrate how Otsuka is a “big venture” company at heart, applying a youthful spirit of creativity in everything it does.
Otsuka Pharmaceutical is a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan. The Otsuka group of companies employed 47,000 people worldwide and had consolidated sales of approximately USD 13.3 billion in 2020.
In Singapore, in 2015 Otsuka first arranged an indirect market presence through an agent for our mental health-related therapies. In 2017, Otsuka Pharmaceuticals (Singapore) Pte. Ltd. was established and has built a direct presence to commercialize medicines in the areas of mental health, nephrology, and cardiology.
Mental wellbeing has been of growing interest in Singapore and around the world. Otsuka is a leading-edge innovator in digital medicines related to mental health and has started assessment of a digital therapeutic candidate for the Singaporean market. Also, in collaboration with our consumer products business, in 2020 Otsuka started a project in Singapore to support a more preventative approach toward mental illness.
We’re committed to advance treatments for illness and help sustain day-to-day well-being for people in Singapore.
|Sanofi ranks among the top 3 pharmaceutical companies in Singapore. With a workforce of more than 350 people, everyone in Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.|
Sanofi Singapore houses Sanofi’s regional head offices, and a strong Clinical Research Unit, which oversees clinical trials conducted in 150 centres across Southeast Asia. We also have a manufacturing facility in Singapore that is responsible in producing pharmaceutical active ingredient which is used in key Sanofi products globally.
With more than 100,000 people in 100 countries, representing more than 145 nationalities, our ambition is to support people facing big and small health challenges, be it lifelong or temporary. Wherever people live and whenever we can make a difference, we seek to protect, enable and support those who face health challenges so they can live life to its full potential. All that we do is about Empowering Life.
To learn more, visit https://www.sanofi.com.my
SMHC2021 offers a variety of sponsorship and exhibit options, including but not limited to:
For more information, please contact Secretariat at email@example.com
Stay in the Know
Be part of the SMHC mailing list to stay notified of upcoming events and happenings.
Now you will receive all the latest conference updates straight in your mailbox.
Please check your inbox or spam folder for email confirmation. Don't forget to add SMHC2021@icsevents.com to your contacts.Click here to close this window